Results for AFP, GPC3 and EpCAM could further be validated in an independent validation cohort of HCC patients as well as cirrhotic livers without HCCs (Supplementary Figure S4, Table 1B). This evidence concerns the gene EPCAM and hepatocellular carcinoma.